Catalina Capital Group, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 2018090 Torrance, CA

Position in GILD

as of Mar 31, 2026 · filed Apr 23, 2026 Compact

Position Value

$203,619

-$243,821 QoQ

Shares Held

1,461

-69.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.28%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

4 quarters on record

Voting authority Sole 99% Shared 0% None 1%

Healthcare · as of Mar 31, 2026

Catalina Capital Group, LLC holds $2,098,375 across 4 Drug Manufacturers - General names. GILD ranks #4 (9.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,214	$1,116,600
2	ABBV	AbbVie Inc.	2,511	$546,117
3	MRK	Merck & Co., Inc.	1,929	$232,039
4	GILD	Gilead Sciences, Inc. This page	1,461	$203,619

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$203,619	1,461	-69.8%	Shares	Sole	2026-04-23
2024-12-31	$447,440	4,844	+25.6%	Shares	Sole	2025-01-24
2024-09-30	$323,370	3,857	+38.4%	Shares	Sole	2024-10-30
2024-03-31	$204,074	2,786	—	Shares	Sole	2024-05-03
No filing history on record for this holder in this stock.